跳至主要内容
临床试验/NCT00041561
NCT00041561终止3 期

The Effects of Inhaled Nitric Oxide in the Treatment of Acute Hypoxemic Respiratory Failure (AHRF) In Pediatrics

Mallinckrodt16 个研究点 分布在 1 个国家目标入组 55 人开始时间: 2002年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
终止
发起方
Mallinckrodt
入组人数
55
试验地点
16
主要终点
arterial blood gases

研究概览

简要总结

The purpose of this study is to determine the effect of nitric oxide for inhalation on the duration of mechanical ventilation in pediatric patients with AHRF.

详细描述

Patients will receive 5-ppm study gas (nitric oxide for inhalation or placebo) until Day 28 or extubation, whichever comes first. The following will be performed / recorded at specified times during the study: arterial blood gases, ventilator settings, methemoglobin, PRISM III score, and patient positioning. Selected centers will also be performing plasma cytokine assays, broncho-alveolar lavage fluid assays and a 6 month follow-up assessment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
— 至 16 Years(Child)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

2

Placebo Comparator

Nitrogen gas

干预措施: Nitrogen gas (Drug)

1

Experimental

Inhaled Nitric Oxide

干预措施: inhaled nitric oxide (Drug)

结局指标

主要结局

arterial blood gases

时间窗: baseline through 24 hours and extubation

次要结局

  • broncho-alveolar lavage fluid(baseline, 48 hours and day 5)
  • Prone position(baseline then daily)
  • methemoglobin(baseline, hour 4 and 24 hours)

研究者

发起方
Mallinckrodt
申办方类型
Industry
责任方
Sponsor

研究点 (16)

Loading locations...

相似试验